Evidence map›Paper›PMID 21821380›Full record

ArticleJournal of vascular surgery2011

Diastolic function predicts survival after renal revascularization.

Racheed J Ghanami, Hamza Rana, Timothy E Craven, John Hoyle, Matthew S Edwards, Kimberley J Hansen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of vascular surgery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Racheed J GhanamiDepartment of Vascular and Endovascular Surgery, Wake Forest University Baptist Medical Center, Winston-Salem, NC 27157, USA.
Hamza Rana
Timothy E Craven
John Hoyle
Matthew S Edwards
Kimberley J Hansen
Atrium Health Wake Forest Baptist · US

Funding

Mentored Clinical Scientist Program in Vascular MedicineK12HL083763 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GODSHALL, CHRISTOPHER JAY · 2007 to 2012
$2.1M
Embolic Protection During Renal Artery StentingK23HL083981 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI EDWARDS, MATTHEW S · 2006 to 2010
$537k
NHLBI NIH HHS K12 5K12HL083763NHLBI NIH HHS K12 HL083763NHLBI NIH HHS K23 HL083981
6 · The paper itself

Abstract

purposeThe purpose of this study was to define the relationship between left ventricular diastolic function and survival after renal revascularization.

methodsSeventy-six adult patients (49 women, 27 men; mean age: 63 ± 13 years) with preoperative echocardiography who underwent renal revascularization for atherosclerotic disease were identified. Diastolic function was estimated from the early diastolic transmitral flow velocity (E), the atrial transmitral flow velocity (A), and the mitral annular tissue doppler velocity (e'). Patients were divided into two groups of diastolic dysfunction as either none/mild (E/A ≤ 0.75, E/e' <10) or moderate/severe (E/A >0.75, E/e' ≥ 10). Perioperative and follow-up mortality were determined from a prospective vascular database and the National Death Index. Descriptive statistics were calculated and postoperative survival was estimated by product-limit methods. Associations between preoperative factors, perioperative factors, and follow-up survival were examined using proportional hazards regression models. A forward stepwise variable selection procedure was used to select a "best" model to predict follow-up survival.

resultsSeventy-six patients were followed for an average of 41.9 months after renal revascularization. Within this group, 47 of 76 patients (61.8%) were identified as having moderate or severe diastolic dysfunction. Diastolic dysfunction had no apparent association with abnormal systolic function. The mean ejection fraction for those with moderate/severe diastolic dysfunction was 57.7% ± 11.5%. When comparing the moderate/severe and none/mild groupings of diastolic dysfunction, there was a significant difference in left ventricular mass index (151.9 ± 48.9 vs 125.3 ± 31.7; P = .0087). There were five deaths in the perioperative period and 20 deaths on follow-up. Among perioperative survivors, hypertension was cured or improved in 82% of the none/mild group and 53% of the moderate/severe group (P = .012). In multivariable analysis, none/mild diastolic dysfunction was significantly and independently associated with an improvement in blood pressure after revascularization (odds ratio [OR], 6.2; 95% confidence interval [CI], 1.4-28.6; P = .018). Ejection fraction was not associated with survival. After forward variable selection, moderate/severe diastolic dysfunction (hazard ratio [HR], 5.8; 95% CI 1.4-25; P = .018) was the only variable to demonstrate a significant and independent association with follow-up survival.

conclusionDiastolic dysfunction, but not systolic dysfunction, was frequent in patients with renovascular disease. Blood pressure response and follow-up survival after renal revascularization demonstrated significant and independent associations with diastolic function. Consideration of diastolic function should be included in the management of patients with atherosclerotic renovascular disease.

Indexed as

Vascular Surgical ProceduresAdultAgedBlood PressureCohort StudiesDiastoleFemaleHumansMaleMiddle AgedPredictive Value of TestsRenal Artery ObstructionSurvival RateTreatment OutcomeVentricular Function, Left

Identifiers

PMID21821380
PMCPMC3230744
OpenAlexW1977145640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.